Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subgingival Microbiota and Longitudinal Glucose Change: The Oral Infections, Glucose Intolerance and Insulin Resistance Study (ORIGINS).

Journal of dental research·2019
Same author

Demographics and anthropometrics impact benefits of health intervention: data from the Reduce Obesity and Diabetes Project.

Obesity science & practice·2019
Same author

Neutrophilic fixed drug eruption: a mimic of neutrophilic dermatoses.

Clinical and experimental dermatology·2018
Same author

Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2018
Same author

Epidermal necrosis with multinucleated keratinocytes: a possible diagnostic clue for dermatitis artefacta in children.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015
Same author

Periodontal Bacteria and Prediabetes Prevalence in ORIGINS: The Oral Infections, Glucose Intolerance, and Insulin Resistance Study.

Journal of dental research·2015
Same journal

Toxoplasmic encephalitis.

Diseases of the nervous system·2010
Same journal

Prevention of postconvulsive hyperexcitability in electro-shock therapy.

Diseases of the nervous system·2010
Same journal

The thematic apperception test.

Diseases of the nervous system·2010
Same journal

Care and treatment of the mentally ill in Illinois.

Diseases of the nervous system·2010
Same journal

Group psychotherapy in a convalescent hospital; organization and method.

Diseases of the nervous system·2010
Same journal

Myasthenia gravis.

Diseases of the nervous system·2010
See all related articles

Related Experiment Video

Updated: Jun 7, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Disseminated sclerosis

M ROSENBAUM, I M SCHEINKER

    Diseases of the Nervous System
    |October 29, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    SCLEROSIS/disseminated

    More Related Videos

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
    04:44

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

    Published on: June 16, 2020

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
    06:19

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

    Published on: September 9, 2022

    Related Experiment Videos

    Last Updated: Jun 7, 2026

    Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
    09:46

    Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

    Published on: September 21, 2021

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
    04:44

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

    Published on: June 16, 2020

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
    06:19

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

    Published on: September 9, 2022